Let's Talk Alzheimer's
di BrightFocus Foundation
Trontinemab: A New Brain-Penetrant Alzheimer’s Therapy | Dr. Gil…
Informazioni su questo podcast
Welcome to Let’s Talk Alzheimer’s, your place to go for trusted insights from leading scientists and medical experts. Get the latest information on diagnosis, risk reduction, clinical trials, and the latest treatments. Presented by BrightFocus Foundation's Alzheimer's Disease Research program.
Episodi
- Trontinemab: A New Brain-Penetrant Alzheimer’s Therapy | Dr. Gil Rabinovici · 52 min · Episodio 13A new generation of Alzheimer’s therapies is tackling one of medicine’s toughest challenges: delivering drugs to the brain. Renowned Alzheimer’s researcher Dr. Gil Rabinovici…
- How Focused Ultrasound is Changing Alzheimer's Treatment | Dr. Ali Rezai · 48 min · Stagione 1 Episodio 12What if a noninvasive technology using sound waves could help unlock new possibilities for Alzheimer’s research and care? Dr. Ali R. Rezai, a leader in neuroscience and…
- Reducing Dementia Risk: What New Research Reveals | Dr. Zaldy Tan · 55 min · Stagione 1 Episodio 11Up to 45% of dementia cases may be preventable or delayed by addressing modifiable risk factors, recent research shows. Join Dr. Zaldy Tan as he discusses the latest evidence on…
- Can Brain Tissue Be Regenerated? Inside the ReGenBrain Trial | Dr. Roberta Diaz Brinton · 14 min · Stagione 1 Episodio 10Can brain tissue be regenerated? We spoke with Roberta Diaz Brinton, PhD, director of the Center for Innovation in Brain Science at the University of Arizona, about the…
- Lewy Body, Alzheimer’s & Mixed Dementias Explained | Dr. James Galvin · 39 min · Stagione 1 Episodio 9Lewy body dementia is a form of dementia caused by abnormal protein deposits in the brain known as "Lewy bodies,” with symptoms that can resemble those of Parkinson's disease…
- Managing Agitation in Alzheimer's Dementia | Dr. Brent Forester · 21 min · Stagione 1 Episodio 8Agitation is one of the most common and challenging symptoms of Alzheimer’s disease, often causing distress for both individuals living with dementia and their caregivers. Dr…
- Stroke, Vascular Dementia, Alzheimer’s: What’s the Difference? | Dr. Jason Hinman · 34 min · Stagione 1 Episodio 7Vascular dementia is the second-most common form of dementia and often develops after a stroke. In this episode, Dr. Jason Hinman of UCLA explains how disrupted blood flow to the…
- The Gut-Brain Connection: How the Microbiome May Influence Alzheimer’s Risk | Dr. Beau Ances · 40 min · Stagione 1 Episodio 6Could the trillions of bacteria in your gut affect your brain health and risk for Alzheimer’s disease? Emerging research suggests the gut microbiome may play an important role in…
- Alzheimer’s and Gum Disease: Exploring the Role of Oral Bacteria in Brain Health | Dr. Michael Detke · 40 min · Stagione 1 Episodio 5Could bacteria linked to gum disease play a role in Alzheimer’s disease? Emerging science suggests that P. gingivalis, a bacterium associated with gum disease, may contribute to…
- Inside the Alzheimer’s Drug Pipeline: What New Clinical Trials Mean for the Future | Dr. Jeffrey Cummings · 21 min · Stagione 1 Episodio 4Exciting advances in understanding Alzheimer’s biology, genetics, and biomarkers are driving new medicines, devices, and prevention strategies. In 2025 alone, 182 clinical trials…
- Lifestyle & Brain Health: U.S. POINTER Study | Dr. Laura D. Baker · 33 min · Stagione 1 Episodio 3Can everyday lifestyle choices really protect your memory? Dr. Laura Baker, professor at Wake Forest University School of Medicine, shares insights from the groundbreaking U.S…
- Detecting Alzheimer’s: How to Recognize Early Signs | Dr. Sharon Cohen · 43 min · Stagione 1 Episodio 2Detecting subtle changes in memory or thinking can be unsettling, but understanding what’s behind those changes can lead to critical early diagnosis—or even rule out Alzheimer’s…
- Leqembi & Kisunla: New Alzheimer's Treatments Explained | Dr. Armen J. Moughamian · 35 min · Stagione 1 Episodio 1Just three years ago, there were no FDA-approved treatments that targeted the underlying causes of Alzheimer’s—only medications that modified symptoms. Today, two FDA-approved…
- Let's Talk Alzheimer's TRAILER · 1 minLet’s Talk Alzheimer’s is a new podcast from BrightFocus Foundation’s Alzheimer’s Disease Research program that helps listeners understand Alzheimer’s disease and other dementias…








